Quick Takeaways
- Michael Myers filed SCHEDULE 13D/A for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX).
- Disclosed ownership: 4.9%.
- Date of event: 27 Jan 2025.
Michael Myers - 27 Jan 2025 SCHEDULE 13D/A Report for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX)
- Filing Manager
- Michael Myers
- Reporting Manager
- Michael Myers
- Symbol
- QNRX
- Shares outstanding
- 19,167,959 shares
- Disclosed Ownership
- 939,230 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13D/A
- Filing time
- 28 Jan 2025, 16:44:09 UTC
- Date of event
- 27 Jan 2025
- Previous filing
- 02 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael Myers disclosed 4.9% ownership in Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX) on 27 Jan 2025."
What Changed
- Previous schedule filing date: 02 Jan 2025.
- Current filing was accepted on 28 Jan 2025, 16:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Michael Myers | 4.9% | 939,230 | 939,230 | 0 | /s/ Michael Myers | Dr. Michael Myers | 0001959547 |